Get the Stockscreener App
34.46
0.44%
0.15
Omnicell Inc stock is traded at $34.46, with a volume of 341.58K.
It is up +0.44% in the last 24 hours and down -14.17% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$34.31
Open:
$33.8
24h Volume:
341.58K
Relative Volume:
0.52
Market Cap:
$1.57B
Revenue:
$1.18B
Net Income/Loss:
$2.05M
P/E Ratio:
797.69
EPS:
0.0432
Net Cash Flow:
$66.94M
1W Performance:
-1.80%
1M Performance:
-14.17%
6M Performance:
+11.59%
1Y Performance:
-1.94%
1-Day Range:
$33.38
$34.76
1-Week Range:
$32.19
$34.85
52-Week Range:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
34.46 | 1.57B | 1.18B | 2.05M | 66.94M | 0.0432 |
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Published on: 2026-03-25 03:49:16 - baoquankhu1.vn
Should You Continue to Hold OMCL Stock in Your Portfolio? - TradingView
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Pharmaceutical Unit Dose Packaging Market Is Going to Boom | AptarGroup Inc. • Omnicell Inc. • Becton - openPR.com
OMCL PE Ratio & Valuation, Is OMCL Overvalued - Intellectia AI
Pharmacy Inventory Management Software Solutions And Cabinets - openPR.com
Update Recap: What chart patterns are forming on Omnicell Inc2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
Medication Therapy Management Market Current Impact to Make Big Changes | CVS Health, Walgreens, Omnicell - openPR.com
Omnicell, Inc. (OMCL): A bull case theory - MSN
Omnicell (NASDAQ:OMCL) EVP Corey Manley Sells 7,405 Shares - MarketBeat
Omnicell (NASDAQ: OMCL) CEO RSUs vest; shares withheld for taxes - Stock Titan
Omnicell (OMCL) COO gains 37,409 shares; 8,456 withheld for taxes - Stock Titan
Omnicell (OMCL) EVP Manley reports PSU vesting, tax withholding and share sale - Stock Titan
Q4 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
OMCL (NASDAQ: OMCL) affiliate sales; 7,405 restricted shares vest on 03/15/2026 - Stock Titan
Benchmark reiterates Omnicell stock rating on product cycle outlook - Investing.com Australia
Benchmark reiterates Omnicell stock rating on product cycle outlook By Investing.com - Investing.com UK
Pier Capital LLC Reduces Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (NASDAQ:OMCL) Rating Increased to Hold at Zacks Research - MarketBeat
Telepharmacy Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Omnicell (OMCL) to Participate in Benchmark's Virtual Meeting on March 11 - GuruFocus
How Omnicell Inc. (OMCL) Affects Rotational Strategy Timing - Stock Traders Daily
Dynamic Technology Lab Private Ltd Acquires 24,738 Shares of Omnicell, Inc. $OMCL - MarketBeat
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Quantbot Technologies LP Purchases Shares of 25,813 Omnicell, Inc. $OMCL - MarketBeat
Pharmacy Repackaging Systems Market Is Going to Boom Rapidly | - openPR.com
Intech Investment Management LLC Sells 135,679 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story - Sahm
Zacks Research Increases Earnings Estimates for Omnicell - MarketBeat
Aug Patterns: Is Omnicell Inc a play on infrastructure spendingGold Moves & High Conviction Investment Ideas - baoquankhu1.vn
How The Titan XT Cycle Is Rewriting The Omnicell (OMCL) Investment Story - Yahoo Finance
Will Strong Q4 Beat and Software Pivot Change Omnicell's (OMCL) Investment Narrative? - Yahoo Finance
JPMorgan Chase & Co. Sells Omnicell, Inc. $OMCL Shares - National Today
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
Assessing Omnicell (OMCL) Valuation As ANiGENT Deal Accelerates Shift To Software And Services - simplywall.st
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - simplywall.st
Omnicell, Inc. (OMCL): A Bull Case Theory - Finviz
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.50%
2.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):